¶ … PARKINSON'S DISEASE
UNDERSTANDING THE PARKINSON'S DISEASE
Understanding Parkinson's disease
Description
Parkinson disease is a progressive neurological problem that affects people of all ages and races. It is a very common condition. It is estimated that about 70, 000 Australians live with this disease. The average diagnostic age is 65 years, however, that does not rule out the possibility of young people developing Parkinson. In young people, the condition is known as Young Onset Parkinson Disease. Diagnosing Parkinson disease is not an easy task. There are no known laboratory tests like brain scan or blood test, so it is important to ensure a specialist such as a neurologist carries out the diagnosis. The specialist is expected to look for any known physical signs of the condition and take the detailed history of the symptoms of Parkinson's disease. There is still no known cause of Parkinson's disease in people. Many theories exist as to why people develop this condition, most of which amount to the belief that several factors could be responsible. One underlying cause of the symptoms of this condition is related to a reduction in the production of the important brain chemical known as dopamine. Most of the brain cells responsible for the production of dopamine is the Basal Ganglia found at the centre of the brain. Lack of dopamine implies that people cannot move freely. The symptoms of Parkinson's disease build up quite slowly and progress gradually with time. Every individual is affected in a different way by the disease and the rate of progression varies from one individual to another. Naturally, Parkinson's disease does not kill people, so living with the condition for a very long time is possible, though symptoms worsen with age (Parkinson's Australia, n.d).
Incidence/Prevalence
There is no available data for ascertained PD diagnosis that can be employed for the estimation of the prevalence of this condition. This is due to the unavailability of any definitive test to confirm PD diagnosis, which leads to the possibility of misdiagnosis or under-diagnosis. The technique employed in the 2007 Access Economics research to evaluate the prevalence of PD was gotten from the analysis of Pharmaceutical Benefits Scheme (PBS) data. Conservatively, it was estimated that over 54, 700 Australians had PD in 2005. About 8,900 new cases were believed to have developed in 2005. Incidence is about how many new PD cases reported. The Access Economics research of 2007 estimated 2005 incidence employing the same methodology as Begg et al., (2007), depending on the prevalence rate estimated, the remission rate of which was believed to be zero as well as the relative mortality risk. The Access Economics research of 2007 estimated that there were approximately 8, 900 new PD cases in 2005. Employing the demographic data of 2011 to the 2007 estimated incidence rate, an estimated incidence PD from 2010-2011 was put at 10, 500 (Deloitte, 2011).
Classification
Sometimes, Parkinson's disease is described as early, moderate or advanced. Early condition is when an individual experiences minor tremors or stiffness but can still carry out daily tasks and every other important activity. People who have been newly diagnosed with the condition are in this category. Moderate condition describes individuals who start experiencing limited movement. A person with moderate PD may experience moderate tremors and very slow movements. Advanced condition describes the stage when the individual becomes obviously limited in his/her activities, irrespective of treatment.
Daily symptom changes, medicine adverse effects that hinder treatment, and lack of independence in daily life activities are quite common. A person suffering advanced Parkinson's disease may experience severe problems with speech, posture and movement (Parkinson's Disease Health Center, n.d).
Epidemiology
The etiology of most Parkinson's Disease (PD) is still unknown, with several theories on genoenvironmental communication being proposed. The incidence and PD prevalence is known to exponentially increase with age, and are a little bit higher in men than they are in women. Several putative risk factors can be linked to PD; age is the most consistently accepted factor. A major proposed risk factor is exposure to pesticides, while an inverse relationship existing between coffee consumption and smoking and PD has been reported in other studies. More cases of PD appear in Older people (Lai & Tsui, 2001).
Both the incidence and prevalence of PD are known to greatly vary among different age groups. PD is far less common in people below the age of 50 and steadily increases after that until the 9th decade. The reduction in most elderly people in some researches possibly come from the few...
Huntington's disease (HD) was the first autonomic dominant disorder for which genetic prediction became possible" (Harper, et al., 2000, Journal of Medical Genetics, p. 567). HD is a disease that occurs due to an inherited disorder leading to the death of brain cells. A diagnosis of HD is accomplished through genetic testing which can be implemented at any age regardless of whether the symptoms manifest or not. Although, the specific
Psychopharmocology: Psychotic Disorders Psychopharmacology: Psychotic disorders Accepted psychological and biological theories regarding the causes of each disorder Psychosis is an undefined syndrome that manifests in delusions, bizarre behavior, hallucinations, losing touch with reality. The condition is attributed to a variety of conditions including primary psychiatric complications and medical complications such as dementia, central lobe epilepsy, Schizophrenia and related disorders, medical complications, abnormalities in metabolism, endocrine and neurologic disease. It also includes drug and
Psychopharmacology Website: www.bap.org.uk The British Association of Psychopharmacology (BAP)(n.d.) is a scholarly society and enlisted philanthropy. It advances exploration and instruction in psychopharmacology and related zones, and unites individuals in the educated community, well-being administrations, and industry. Shaped in 1974, it is the biggest such national relationship in Europe, and the second biggest in the world. The website has a lot of different content available that would help me in my coursework.
Alzheimer's disease has developed into a major health concern for the elderly population throughout the world. This degenerative brain disorder was first described by Alois Alzheimer in 1907. Today Alzheimer's is one of the most prevalent forms of brain disorders contributing to as much as 50 to 70% of all reported cases of dementia. Over the years the study of early onset Alzheimer's disease (pre-senile AD) has kind of overshadowed
Conflict of Interest Should I, as principal investigator of a new drug that potentially could help those who suffer from Parkinson's disease, enroll my father, who has Parkinson's disease, in the study? My Answer to the Question First of all, the study entails a brand new drug that has not been researched previously. I am to study the "efficacy and safety" of a drug, we can assume is powerful, whether it is really
healthy individual is infected with a bacteria or virus, the body identifies the virus as an invader, and therefore produces the antibodies, which is the human body's immune system, to destroy the virus to assist the person to recover and become healthy. Meanwhile, vaccination is the process of stimulating the active immune system to fight disease in the body, and vaccine will boost the body active immunity to fight
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now